NCT04246190View on ClinicalTrials.gov

A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396

PHASE1UnknownINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

April 10, 2020

Study Completion Date

July 16, 2020

Conditions
Type2 Diabetes Mellitus
Interventions
DRUG

CKD-501 and D759

Reference drug, CKD-501 1T and D759 1T, QD, PO

DRUG

CKD-396

Reference drug, CKD-396 1T, QD, PO

Trial Locations (1)

Unknown

Yonsei University Severance Hospital, Soeul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY